By DDW Editor Reece Armstrong The threat of antimicrobial resistance (AMR) has long been a talking point for those invested in healthcare and life sciences. Indeed, for many, it is a looming threat for which inaction could result in very serious consequences for healthcare systems worldwide. AMR is currently listed as one of the top […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!